Maria Tzeli

Mrs. Maria Tzeli


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2025 in Toxics
Verified
Journal Article
Open access
PDF file
Anastasios PotirisAnastasios Potiris
Anastasios Potiris
NDNikoletta Daponte
Nikoletta Daponte
EMEfthalia Moustakli
Efthalia Moustakli
AZAthanasios Zikopoulos
Athanasios Zikopoulos
EKEriketi Kokkosi
Eriketi Kokkosi
SSSofoklis Stavros
Sofoklis Stavros
Environmental stressors during the crucial period of fetal development can have a substantial impact on long-term health outcomes. A major concern is dietary exposure to endocrine-disrupting chemicals (EDCs), which can readily cross the placenta and disrupt fetal hormonal signaling and developmental programming. Examples of these chemicals include bisphenols, phthalates, pesticides, and persistent organic pollutants (POPs). Prenatal exposure to EDC has been associated with long-term effects in children, including immune disruption, metabolic dysregulation, impaired neurodevelopment, and reproductive alterations, as evidenced by human cohort studies and experimental models. Epigenetic reprogramming, direct interference with endocrine signaling, and oxidative stress (OS) are hypothesized pathways for these adverse consequences, which often combine to produce long-lasting physiological changes. This narrative review summarizes current research on maternal dietary exposure to EDCs during pregnancy, highlighting associations with adverse child health outcomes. It also discusses the growing evidence of transgenerational effects, the potential mechanisms linking prenatal exposure to long-term outcomes, and the importance of understanding the roles of timing, dosage, and chemical type. By highlighting the necessity of focused interventions to lower maternal EDC exposure and lessen threats to the health of offspring, the review concludes by discussing implications for future research, preventive measures, and public health policy.

3 April 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
Dimitra MetallinouDimitra Metallinou
Dimitra Metallinou
GKGrigorios Karampas
Grigorios Karampas
MPMaria Loukia Pavlou
Maria Loukia Pavlou
MLMaria Ioanna Louma
Maria Ioanna Louma
AMAIMILIA MANTZOU
AIMILIA MANTZOU
NICOLETTA IACOVIDOUNICOLETTA IACOVIDOU
NICOLETTA IACOVIDOU
Neonatal brain injury (NBI) is a critical condition for preterm neonates with potential long-term adverse neurodevelopmental outcomes. This prospective longitudinal case–control study aimed at investigating the levels and prognostic value of serum neuron-specific enolase (NSE) during the first 3 days of life in preterm neonates (<34 weeks) that later developed brain injury in the form of either periventricular leukomalacia (PVL) or intraventricular hemorrhage (IVH) during their hospitalization. Participants were recruited from one neonatal intensive care unit, and on the basis of birth weight and gestational age, we matched each case (n = 29) with a neonate who had a normal head ultrasound scan (n = 29). We report that serum NSE levels during the first three days of life do not differ significantly between control and preterm neonates with NBI. Nevertheless, subgroup analysis revealed that neonates with IVH had significantly higher concentrations of serum NSE in comparison to controls and neonates with PVL on the third day of life (p = 0.014 and p = 0.033, respectively). The same pattern on the levels of NSE on the third day of life was also observed between (a) neonates with IVH and all other neonates (PVL and control; p = 0.003), (b) neonates with II–IV degree IVH and all other neonates (p = 0.003), and (c) between control and the five (n = 5) neonates that died from the case group (p = 0.023). We conclude that NSE could be an effective and useful biomarker on the third day of life for the identification of preterm neonates at high risk of developing severe forms of IVH.

14 January 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AZAthanasios Zikopoulos
Athanasios Zikopoulos
EMEfthalia Moustakli
Efthalia Moustakli
Anastasios PotirisAnastasios Potiris
Anastasios Potiris
KLKonstantinos Louis
Konstantinos Louis
IAIoannis Arkoulis
Ioannis Arkoulis
SSSofoklis Stavros
Sofoklis Stavros
Background: Despite significant advances in genetics, immunology, and endometrial research, the underlying cause of nearly half of recurrent pregnancy loss (RPL) cases remains unknown. This highlights the limitations of conventional diagnostic approaches and underscores the need for methods that can detect complex, subtle biological patterns. Objectives: To summarize and critically assess how artificial intelligence (AI) is changing our knowledge of, ability to predict, and future therapeutic management of RPL, with a focus on machine learning (ML) approaches that identify latent biological pathways and multifactorial contributors to pregnancy loss. Methods: This narrative review summarizes contemporary research on AI applications in reproductive medicine. Research using imaging, proteomic, genomic, clinical, and multi-omics information to create predictive or mechanistic models associated with RPL provided evidence. Results: AI-based approaches are increasingly demonstrating the ability to detect complex interactions among environmental, immunological, biochemical, and genetic factors associated with RPL. ML and deep learning (DL) models enhance prognostic accuracy, identify novel candidate biomarkers, and provide insights into the systemic and molecular mechanisms underlying pregnancy loss. Integrating heterogeneous data through AI supports the development of personalized reproductive profiles and can improve prediction and counseling. Conclusions: AI has the potential to improve both personalized prediction and mechanistic understanding of RPL. However, clinical translation is currently hampered by a number of important issues, including small and diverse datasets, conflicting diagnostic definitions, limited external validation, and a lack of prospective clinical trials. To responsibly integrate AI tools into reproductive care, these limitations must be addressed.

30 October 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
MTMaria Tzeli
Maria Tzeli
MAMaria Alexiou
Maria Alexiou
Antigoni SarantakiAntigoni Sarantaki
Antigoni Sarantaki
GKGiannoula Alexios Kyrkou
Giannoula Alexios Kyrkou
DCDIMITRIOS CHARALAMPOPOULOS
DIMITRIOS CHARALAMPOPOULOS
Dimitra MetallinouDimitra Metallinou
Dimitra Metallinou
Background/Objectives: The Parental Stressor Scale: Neonatal Intensive Care Unit (PSS:NICU) is one of the most widely used tools for assessing parental stress in neonatal intensive care settings. This study aimed to translate, culturally adapt and validate the PSS:NICU in a Greek cohort. Methods: A multicenter, cross-sectional study was conducted with 150 parents (89 mothers, 61 fathers; mean age = 34.1 years, SD = 7.2) of hospitalized neonates from three Greek NICUs. The translation followed forward–backward procedures, expert review, and pilot testing. Data were analyzed for internal consistency, factorial validity, and group differences. Results: Confirmatory factor analysis supported the adequacy of the original three-factor structure (Sights and Sounds, Infant Behavior and Appearance, and Parental Role Alteration). Cronbach’s alpha and McDonald’s omega coefficients indicated excellent reliability for the total scale and its subscales. Female participants reported higher stress levels than males in most dimensions. Conclusions: The Greek version of the PSS:NICU demonstrated strong psychometric properties and cultural relevance. This adaptation provides a valid and reliable tool for assessing parental stress in Greek NICUs and facilitates cross-cultural comparisons and the development of targeted psychosocial interventions.

Verified
Journal Article
Open access
PDF file
ATHANASIOS ZACHARIOUATHANASIOS ZACHARIOU
ATHANASIOS ZACHARIOU
EMEfthalia Moustakli
Efthalia Moustakli
AZAthanasios Zikopoulos
Athanasios Zikopoulos
MFMaria Filiponi
Maria Filiponi
Anastasios PotirisAnastasios Potiris
Anastasios Potiris
SSSofoklis Stavros
Sofoklis Stavros
Approximately 7% of males globally suffer from male infertility, which is becoming more widely acknowledged as a clinical indicator of potential health hazards as well as a cause of reproductive failure. Among these, cancer has become a significant worry due to mounting evidence that spermatogenesis impairment is associated with increased risk of prostate, testicular, and other cancers. Male infertility may be an early clinical manifestation of systemic genomic instability due to shared biological pathways, such as Y-chromosome microdeletions (AZF regions), germline DNA repair defects, mutations in tumor suppressor genes (e.g., BRCA1/2, TP53), mismatch repair gene mutations (e.g., MLH1, MSH2), and dysregulated epigenetic profiles. This narrative review covers the most recent research on prognostic markers of cancer in infertile men. These include molecular biomarkers such as genetic, epigenetic, and proteomic signatures; endocrine and hormonal profiles; and clinical predictors such as azoospermia, severe oligozoospermia, and a history of cryptorchidism. The possibility of incorporating these indicators into risk stratification models for precision medicine and early cancer surveillance is highlighted. For this high-risk group, bridging the domains of andrology and oncology may allow for better counseling, earlier detection, and focused therapies.

25 June 2026 in Biology
Verified
Journal Article
Open access
PDF file
SSSofoklis Stavros
Sofoklis Stavros
Panagiotis ChristopoulosPanagiotis Christopoulos
Panagiotis Christopoulos
SDStefanos Dafopoulos
Stefanos Dafopoulos
CCCHRISTODOULAKI CHRYSI
CHRISTODOULAKI CHRYSI
EMEfthalia Moustakli
Efthalia Moustakli
PDPeter Drakakis
Peter Drakakis
The pineal gland regulates circadian physiology through the periodic production of melatonin (MLT). In addition to its established role as a chronobiotic agent, MLT regulates redox homeostasis and mitochondrial physiology. Mitochondria and redox-active molecules, particularly reactive oxygen species (ROS), play essential roles in reproduction, including gamete physiology, fertilization, and early embryonic development. Although excessive oxidative stress (OS) impairs fertility, controlled ROS signaling is necessary for normal reproductive function. This comprehensive review synthesizes current evidence regarding MLT as a key intermediary linking circadian signaling with mitochondrial physiology and redox homeostasis. We discuss molecular pathways through which MLT regulates mitochondrial function, including activation of the Nrf2 signaling pathway, modulation of mitochondrial permeability transition, regulation of electron transport chain (ETC) efficiency, and apoptotic signaling. Furthermore, this study investigates MLT’s ability to scavenge free radicals and activate antioxidant defense mechanisms. Moreover, we review novel findings regarding the effects of MLT in experimental animals and humans, assisted reproductive technologies (ART) such as in vitro fertilization (IVF), and consider the translational significance of the hormone as an enhancer of fertility. We also highlight gaps in the literature, including methodological inconsistencies, supraphysiologic doses, and insufficient data from large human cohorts. Lastly, we discuss an integrative model whereby MLT may function as an important regulator of mitochondrial redox balance, with potential implications for reproductive physiology and reproductive outcomes, and propose new avenues for investigation.